Close

Baird Starts iTeos Therapeutics (ITOS) at Outperform

October 7, 2020 4:09 PM EDT Send to a Friend
Baird analyst Michael Ulz initiates coverage on iTeos Therapeutics (NASDAQ: ITOS) with a Outperform rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login